Fortitude Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
1,327
+52
+4% +$53.1K 0.61% 33
2026
Q1
$1.17M Buy
1,275
+334
+35% +$339K 0.53% 35
2025
Q4
$1.01M Buy
941
+128
+16% +$122K 0.43% 40
2025
Q3
$621K Sell
813
-435
-35% -$324K 0.33% 61
2025
Q2
$973K Sell
1,248
-55
-4% -$42.7K 0.56% 33
2025
Q1
$958K Sell
1,303
-184
-12% -$153K 0.69% 25
2024
Q4
$1.15M Buy
1,487
+178
+14% +$147K 0.69% 25
2024
Q3
$1.16M Buy
1,309
+222
+20% +$200K 0.73% 23
2024
Q2
$985K Sell
1,087
-1,083
-50% -$866K 0.59% 27
2024
Q1
$1.69M Sell
2,170
-146
-6% -$104K 0.95% 16
2023
Q4
$1.35M Buy
2,316
+298
+15% +$174K 0.82% 20
2023
Q3
$1.08M Sell
2,018
-7
-0.3% -$3.61K 0.73% 24
2023
Q2
$950K Sell
2,025
-246
-11% -$103K 0.7% 28
2023
Q1
$780K Buy
2,271
+33
+1% +$11.1K 0.6% 37
2022
Q4
$819K Buy
2,238
+127
+6% +$45K 0.7% 33
2022
Q3
$683K Buy
2,111
+135
+7% +$42.8K 0.65% 37
2022
Q2
$641K Buy
1,976
+6
+0.3% +$1.8K 0.59% 43
2022
Q1
$564K Buy
1,970
+395
+25% +$102K 0.3% 52
2021
Q4
$435K Buy
+1,575
New +$399K 0.22% 77

Other funds holding LLY

Fortitude Advisory Group's LLY Position: Q2 2026 in Review

Fortitude Advisory Group increased its Eli Lilly (LLY) stake by 4.1% in Q2 2026, buying an estimated $53.1K and bringing the position to 1,327 shares worth $1.59M. The position accounts for 0.61% of the portfolio, ranked #33.

Fortitude Advisory Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.69M in Q1 2024. 1,785 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fortitude Advisory Group held 1,327 shares of Eli Lilly worth $1.59M as of Q2 2026.
  • Fortitude Advisory Group bought 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
  • Eli Lilly made up 0.61% of Fortitude Advisory Group's portfolio in Q2 2026, its #33 holding.
  • Fortitude Advisory Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • Fortitude Advisory Group's Eli Lilly position peaked at $1.69M in Q1 2024.
  • 1,785 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fortitude Advisory Group's 13F filing for Q2 2026, filed 22 Jul 2026.